Showing results (11-20 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|May 5, 2020
Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitorsKeira A Fieldhouse, Samantha Ukaibe, Erika L Crowley, et al.Drugs in Context|May 7, 2020
Chloroquine and hydroxychloroquine in the context of COVID-19Ashutosh M Shukla, Lennox K Archibald, Aparna Wagle Shukla, et al.Drugs in Context|October 25, 2019
Venetoclax: evidence to date and clinical potentialLuis Miguel Juárez-Salcedo, Viraj Desai, Samir DaliaDrugs in Context|October 25, 2019
Standard care and investigational drugs in the treatment of myelofibrosisDaniela Barraco, Margherita Maffioli, Francesco PassamontiDrugs in Context|August 20, 2016
Evaluating cost benefits of combination therapies for advanced melanomaIvar S Jensen, Emily Zacherle, Christopher M Blanchette, et al.Drugs in Context|December 31, 2021
SAFE - Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workersBrianna M McQuade, Mike Koronkowski, Erin Emery-Tiburcio, et al.Drugs in Context|September 1, 2015
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countriesMarco Turini, Vittoria Piovesana, Pierfrancesco Ruffo, et al.Drugs in Context|July 25, 2018
Febrile seizures: an overviewAlexander Kc Leung, Kam Lun Hon, Theresa Nh LeungDrugs in Context|April 25, 2022
Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndromeSteven H Abman, Nicholas R Fox, M Ibrahim Malik, et al.Pageof 56